Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc. scores highest on Torque (93) and lowest on Price (0). Its PosiPenta is 43.78 out of 100, around the middle of similar companies.
On the Penta Grid this week, Insight Molecular Diagnostics Inc. is Grid #415 of 837 in the Healthcare sector in United States, and Grid #2,526 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. | 43.78 | 0 | 47 | 34 | 93 | 45 |
| Conexeu Sciences Inc. | 29.76 | 5 | 45 | 9 | 32 | 58 |
| Atara Biotherapeutics, Inc. | 55.33 | 0 | 67 | 53 | 93 | 63 |
| ImmuCell Corporation | 54.18 | 23 | 40 | 90 | 56 | 63 |
| NeurAxis, Inc. | 48.34 | 5 | 59 | 86 | 41 | 50 |
| AirSculpt Technologies, Inc. | 43.49 | 41 | 74 | 10 | 48 | 45 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.98 |
| P/B ratio | -4.62 |
EEarnings
| Trailing EPS | ₹-143.97 |
| Forward EPS | ₹-75.77 |
NNitro
| Price | 285.09 |
| 52-week high | 806.02 |
| 52-week low | 229.21 |
| Fall from 52-week high | 64.6% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | -0.11 |
AAnchor
| Beta (price swings) | 1.80 |
| Market cap | ₹932 Cr |
| Insider holding | 21.00% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Insight Molecular Diagnostics Inc.'s PosiPenta score?
Insight Molecular Diagnostics Inc.'s PosiPenta is 43.78 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Insight Molecular Diagnostics Inc. stand on the Penta Grid?
On the Penta Grid this week, Insight Molecular Diagnostics Inc. is Grid #415 of 837 in the Healthcare sector in United States, and Grid #2,526 of 4,000 in United States.
Which PosiPenta pillar is strongest for Insight Molecular Diagnostics Inc.?
Torque (durability), with a score of 93 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Insight Molecular Diagnostics Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Insight Molecular Diagnostics Inc.'s PosiPenta changed since last week?
Yes, it rose 4.48 points, from 39.30 to 43.78.
PositoAI is for research and education only and is not investment advice.